Role of microRNA-505 during tumor progression and metastasis.

[1]  A. Jemal,et al.  Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2024, CA: a cancer journal for clinicians.

[2]  M. Moghbeli,et al.  Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression , 2023, Journal of Translational Medicine.

[3]  M. Moghbeli,et al.  Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells , 2023, Cancer Cell International.

[4]  M. Moghbeli,et al.  PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells , 2023, Cell Communication and Signaling.

[5]  S. Shahidsales,et al.  Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells. , 2023, Pathology, research and practice.

[6]  Na Liu,et al.  Long Non-coding RNA KTN1-AS1 Targets miR-505 to Promote Glioblastoma Progression , 2023, Behavioural neurology.

[7]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[8]  M. Abbaszadegan,et al.  PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells , 2022, Oncology research.

[9]  M. Mojarrad,et al.  Role of microRNAs in regulation of WNT signaling pathway in urothelial and prostate cancers , 2022, Egyptian Journal of Medical Human Genetics.

[10]  M. Moghbeli,et al.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer , 2022, Biomarker research.

[11]  Kun Shi,et al.  H3K27ac-activated lncRNA KTN1-AS1 aggravates tumor progression by miR-505-3p/ZNF326 axis in ovarian cancer , 2022, Annals of translational medicine.

[12]  B. Rah,et al.  Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within , 2022, Frontiers in Pharmacology.

[13]  D. Wishart.  Metabolomics and the Multi-Omics View of Cancer , 2022, Metabolites.

[14]  M. Abbaszadegan,et al.  MicroRNA-217: a therapeutic and diagnostic tumor marker , 2021, Expert review of molecular diagnostics.

[15]  M. Moghbeli,et al.  Molecular mechanisms of the microRNA-132 during tumor progressions , 2021, Cancer Cell International.

[16]  M. Moghbeli,et al.  MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells , 2021, Genes and environment : the official journal of the Japanese Environmental Mutagen Society.

[17]  Bihong Liao,et al.  MicroRNA-505, Suppressed by Oncogenic Long Non-coding RNA LINC01448, Acts as a Novel Suppressor of Glycolysis and Tumor Progression Through Inhibiting HK2 Expression in Pancreatic Cancer , 2021, Frontiers in Cell and Developmental Biology.

[18]  Zhao Liu,et al.  The long noncoding RNA DLGAP1‐AS2 facilitates cholangiocarcinoma progression via miR‐505 and GALNT10 , 2020, FEBS open bio.

[19]  Luwen Zhu,et al.  lncRNA KTN1-AS1 promotes glioma cell proliferation and invasion by negatively regulating miR-505-3p , 2020, Oncology reports.

[20]  Changhua Li,et al.  Ultrasound Microbubble-Mediated microRNA-505 Regulates Cervical Cancer Cell Growth via AKT2 , 2020, Analytical cellular pathology.

[21]  Haitao Huang,et al.  MiRNA505/NET1 Axis Acts as a CD8+ T-TIL Regulator in Non-Small Cell Lung Cancer , 2020, OncoTargets and therapy.

[22]  Z. Jia,et al.  miR-505 suppresses prostate cancer progression by targeting NRCAM , 2020, Oncology reports.

[23]  Lizhi Lv,et al.  microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway. , 2020, Biomarkers in medicine.

[24]  L. Qiao,et al.  MiR-505 inhibits prostate cancer cell invasion, metastasis and epithelial-to-mesenchymal transition through targeting HMGB-1. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[25]  Zhe Cheng,et al.  MicroRNA-505-3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression , 2020, Oncology letters.

[26]  Jian Shen,et al.  LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis. , 2020, Biochemical and biophysical research communications.

[27]  J. Miao,et al.  miR‐505 inhibits proliferation of osteosarcoma via HMGB1 , 2020, FEBS open bio.

[28]  M. Mojarrad,et al.  Genetic and molecular biology of bladder cancer among Iranian patients , 2020, Molecular genetics & genomic medicine.

[29]  F. Espitalier,et al.  Enhanced Amikacin Diffusion With Ultrasound and Microbubbles in a Mechanically Ventilated Condensed Lung Rabbit Model , 2020, Frontiers in Pharmacology.

[30]  W. Qian,et al.  HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy. , 2019, Life sciences.

[31]  Wei Liu,et al.  LncRNA-CTS Promotes Metastasis and Epithelial-to-mesenchymal Transition through regulating miR-505/ZEB2 axis in Cervical Cancer. , 2019, Cancer letters.

[32]  R. Jensen,et al.  Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies , 2019, Expert review of anticancer therapy.

[33]  Xuyang Gong,et al.  LEF-AS1 participates in occurrence of colorectal cancer through adsorbing miR-505 and promoting KIF3B expression. , 2019, European review for medical and pharmacological sciences.

[34]  Sha Ke,et al.  LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia , 2019, Translational cancer research.

[35]  A. Mellor,et al.  Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities. , 2019, Cancer letters.

[36]  M. Moghbeli.  Genetic and molecular biology of breast cancer among Iranian patients , 2019, Journal of Translational Medicine.

[37]  Yang Wang,et al.  MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R , 2019, Bioscience reports.

[38]  Q. Shi,et al.  Polychlorinated biphenyl quinone-induced signaling transition from autophagy to apoptosis is regulated by HMGB1 and p53 in human hepatoma HepG2 cells. , 2019, Toxicology letters.

[39]  Jian Wang,et al.  Downregulation of miR-505 promotes cell proliferation, migration and invasion, and predicts poor prognosis in breast cancer. , 2019, Oncology letters.

[40]  Han Liu,et al.  Extracellular vesicle‑delivered miR‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1. , 2019, International journal of oncology.

[41]  Wen Xu,et al.  LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway , 2019, Journal of experimental & clinical cancer research : CR.

[42]  Luonan Chen,et al.  Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT , 2019, Nature Communications.

[43]  Yingli Wei,et al.  Penetration of different molecule sizes upon ultrasound combined with microbubbles in a superficial tumour model , 2019, Journal of drug targeting.

[44]  San-Yuan Huang,et al.  hnRNPM induces translation switch under hypoxia to promote colon cancer development , 2019, EBioMedicine.

[45]  Lavinia A. Carabet,et al.  Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer , 2019, Molecules.

[46]  W. Jin,et al.  MicroRNA-505 suppresses gastric cancer cell proliferation and invasion by directly targeting Polo-like kinase-1 , 2019, OncoTargets and therapy.

[47]  Huaping Tang,et al.  miR-505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT-NFκB pathway in NSCLC cells , 2018, International journal of molecular medicine.

[48]  Xiaoyu Zhang,et al.  miR‐505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1 , 2018, Journal of cellular biochemistry.

[49]  M. Abbaszadegan,et al.  Genetic and molecular origins of colorectal Cancer among the Iranians: an update , 2018, Diagnostic Pathology.

[50]  W. Zhou,et al.  Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer , 2018, Oncology reports.

[51]  Mingjian Ding,et al.  Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/β-catenin signaling pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[52]  Huan Yang,et al.  miR-505 functions as a tumor suppressor in glioma by targeting insulin like growth factor 1 receptor expression. , 2018, International journal of clinical and experimental pathology.

[53]  C. Fu,et al.  Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway. , 2018, Gene.

[54]  M. Abbaszadegan,et al.  Contribution of KCTD12 to esophageal squamous cell carcinoma , 2018, BMC Cancer.

[55]  Guang Bai,et al.  miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[56]  Yingmei Zhang,et al.  MiR‐505 mediates methotrexate resistance in colorectal cancer by targeting RASSF8 , 2018, The Journal of pharmacy and pharmacology.

[57]  Aaron M. Johnson,et al.  Exploring the mechanisms behind long noncoding RNAs and cancer , 2018, Non-coding RNA research.

[58]  B. Farhood,et al.  Incidence and Mortality of Various Cancers in Iran and Compare to Other Countries: A Review Article , 2018, Iranian journal of public health.

[59]  L. Varani,et al.  High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression , 2018, Oncoimmunology.

[60]  L. Badimón,et al.  miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia. , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  A. Avan,et al.  Role of Wnt/β‐catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer , 2018, Journal of cellular physiology.

[62]  Min Liu,et al.  miR-346 functions as a pro-survival factor under ER stress by activating mitophagy. , 2018, Cancer letters.

[63]  Qian Jianjun,et al.  The involvement of lncRNAs in the development and progression of pancreatic cancer , 2017, Cancer biology & therapy.

[64]  S. Kane,et al.  t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells , 2017, Clinical Cancer Research.

[65]  A. Seyfoori,et al.  Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response , 2017, Pharmacology & therapeutics.

[66]  R. Zhang,et al.  SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex , 2017, Oncogene.

[67]  M. Paronetto,et al.  hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells , 2017, Nucleic acids research.

[68]  K. Rabe,et al.  Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. , 2017, The New England journal of medicine.

[69]  Chunhua Ma,et al.  MicroRNA-505 predicts prognosis and acts as tumor inhibitor in cervical carcinoma with inverse association with FZD4. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[70]  U. Weidle,et al.  Long Non-coding RNAs and their Role in Metastasis. , 2017, Cancer genomics & proteomics.

[71]  U. Stein,et al.  Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression , 2017, Oncotarget.

[72]  Qingquan Liu,et al.  Emerging role of HMGB1 in lung diseases: friend or foe , 2016, Journal of cellular and molecular medicine.

[73]  Ming Li,et al.  Over expression of miR-200c suppresses invasion and restores methotrexate sensitivity in lung cancer A549 cells. , 2016, Gene.

[74]  P. Hou,et al.  Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis , 2016, The Journal of clinical endocrinology and metabolism.

[75]  M. Bianchi,et al.  HMGB1 as biomarker and drug target. , 2016, Pharmacological research.

[76]  A. Brandes,et al.  Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences , 2016, Current Treatment Options in Oncology.

[77]  Guang Bai,et al.  MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1. , 2016, Life sciences.

[78]  R. Moffitt,et al.  Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer , 2016, Oncotarget.

[79]  W. Walther,et al.  S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction , 2016, Cancers.

[80]  H. Lee,et al.  Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor‐infiltrating lymphocytes (TILs) in breast cancer , 2016, Pathology international.

[81]  Ricardo E. Perez,et al.  Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor , 2016, Oncotarget.

[82]  Xiao-cong Zuo,et al.  The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases , 2016, Acta pharmaceutica Sinica. B.

[83]  C. Iacobuzio-Donahue,et al.  TGF-β Tumor Suppression through a Lethal EMT , 2016, Cell.

[84]  Z. Zong,et al.  MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α , 2016, Molecular Cancer.

[85]  Y. Qi,et al.  MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R , 2016, Cellular Physiology and Biochemistry.

[86]  Wei Zhang,et al.  Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway , 2016, Acta Pharmacologica Sinica.

[87]  Y. Suárez,et al.  VEGF-Induced Expression of miR-17–92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis , 2016, Circulation research.

[88]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[89]  M. Jensen.  Synthetic immunobiology boosts the IQ of T cells , 2015, Science.

[90]  O. Hammam,et al.  Impact of epidermal growth factor receptor and transforming growth factor–α on hepatitis C virus‐induced hepatocarcinogenesis , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[91]  Yibin Feng,et al.  The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review , 2015, International journal of molecular sciences.

[92]  Leonora Balaj,et al.  Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study. , 2015, Bioscience.

[93]  D. Tang,et al.  Oxidative stress-mediated HMGB1 biology , 2015, Front. Physiol..

[94]  P. Papageorgis.  TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis , 2015, Journal of oncology.

[95]  B. Han,et al.  High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. , 2015, World journal of gastroenterology.

[96]  Qinbo Yang,et al.  MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation. , 2014, International journal of cardiology.

[97]  Jiayi Wang,et al.  TRIB2 inhibits Wnt/β‐Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β‐TrCP, COP1 and Smurf1, in liver cancer cells , 2014, FEBS letters.

[98]  A. Carroll,et al.  Understanding principles of miRNA target recognition and function through integrated biological and bioinformatics approaches , 2014, Wiley interdisciplinary reviews. RNA.

[99]  C. Heizmann,et al.  RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis , 2014, Oncotarget.

[100]  Wun-Jae Kim,et al.  Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients , 2013, Diagnostic Pathology.

[101]  M. Akram,et al.  Mini-review on Glycolysis and Cancer , 2013, Journal of Cancer Education.

[102]  Lei Shi,et al.  Hepatocellular carcinoma‐associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4‐miR155‐SOCS1‐MMP9 axis , 2013, Hepatology.

[103]  Ye Wang,et al.  Overexpression of SIRT1 promotes high glucose-attenuated corneal epithelial wound healing via p53 regulation of the IGFBP3/IGF-1R/AKT pathway. , 2013, Investigative ophthalmology & visual science.

[104]  T. Schlomm,et al.  High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy , 2013, Prostate Cancer and Prostatic Diseases.

[105]  Jie Zheng,et al.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). , 2012, Oncology letters.

[106]  Jianhua Cao,et al.  Temporal and Spatial Expression of KIF3B after Acute Spinal Cord Injury in Adult Rats , 2012, Journal of Molecular Neuroscience.

[107]  Michiel Postema,et al.  Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges. , 2012, Therapeutic delivery.

[108]  Sanjiv S Gambhir,et al.  Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. , 2012, Radiology.

[109]  S. Joshi,et al.  Nucleosome dynamics: HMGB1 relaxes canonical nucleosome structure to facilitate estrogen receptor binding , 2012, Nucleic acids research.

[110]  R. Setterquist,et al.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.

[111]  E. Rosen,et al.  High-mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma-interaction-dependent and -independent mechanisms. , 2012, Cancer biotherapy & radiopharmaceuticals.

[112]  Lin He,et al.  Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. , 2011, Blood.

[113]  Yusuke Yamamoto,et al.  An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells , 2011, Molecular Cancer.

[114]  M. Salto‐Tellez,et al.  Overexpression of neurone glial‐related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer , 2011, Cancer science.

[115]  M. Adamo,et al.  High fat diet induced insulin resistance and glucose intolerance are gender-specific in IGF-1R heterozygous mice. , 2011, Biochemical and biophysical research communications.

[116]  Karolin Luger,et al.  Nucleosome structure(s) and stability: variations on a theme. , 2011, Annual review of biophysics.

[117]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[118]  K. Maruyama,et al.  Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[119]  Y. Tomari,et al.  The microRNA pathway and cancer , 2010, Cancer science.

[120]  Po-Len Liu,et al.  High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. , 2010, American journal of respiratory cell and molecular biology.

[121]  Angus I Lamond,et al.  Direct interaction between hnRNP‐M and CDC5L/PLRG1 proteins affects alternative splice site choice , 2010, EMBO reports.

[122]  Kai Stühler,et al.  Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas , 2010, Brain pathology.

[123]  R. Larson,et al.  Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. , 2010, Chemico-biological interactions.

[124]  Kjetil Boye,et al.  S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.

[125]  R. Crystal,et al.  A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition , 2009, Nature Cell Biology.

[126]  M. Hatzfeld,et al.  Targeting of p0071 to the midbody depends on KIF3 , 2009, Journal of Cell Science.

[127]  M. Santoro,et al.  Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. , 2009, Cancer research.

[128]  Shan Zhu,et al.  [Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.

[129]  J. Budczies,et al.  Heterogeneous expression of Wnt/β‐catenin target genes within colorectal cancer , 2007, International journal of cancer.

[130]  C. Heizmann,et al.  The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. , 2006, Gastroenterology.

[131]  A. Bresnick,et al.  Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products. , 2006, Arthritis and rheumatism.

[132]  S. Kanaji,et al.  Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric Carcinoma , 2006, Oncology.

[133]  A. Ben-Ze'ev,et al.  The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation. , 2005, Cancer research.

[134]  Nobutaka Hirokawa,et al.  Analysis of the kinesin superfamily: insights into structure and function. , 2005, Trends in cell biology.

[135]  S. Webb,et al.  Interaction of metastasis-inducing S100A4 protein in vivo by fluorescence lifetime imaging microscopy , 2005, European Biophysics Journal.

[136]  P. Johnson,et al.  Systemic therapies for hepatocellular carcinoma , 2004, Expert opinion on investigational drugs.

[137]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[138]  S. Loening,et al.  Polo‐like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades , 2004, The Prostate.

[139]  F. Yuan,et al.  Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair* , 2004, Journal of Biological Chemistry.

[140]  Jun Fan,et al.  A role for the spectrin superfamily member Syne-1 and kinesin II in cytokinesis , 2004, Journal of Cell Science.

[141]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[142]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[143]  Tetsu Akiyama,et al.  Identification of a link between the tumour suppressor APC and the kinesin superfamily , 2002, Nature Cell Biology.

[144]  Marc Payton,et al.  Cyclin E2, the cycle continues. , 2002, The international journal of biochemistry & cell biology.

[145]  W. Liao,et al.  The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.

[146]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[147]  Nobutaka Hirokawa,et al.  Kinesin Superfamily Protein 3 (Kif3) Motor Transports Fodrin-Associating Vesicles Important for Neurite Building , 2000, The Journal of cell biology.

[148]  I. Vernos,et al.  Heterotrimeric Kinesin II Is the Microtubule Motor Protein Responsible for Pigment Dispersion in Xenopus Melanophores , 1998, The Journal of cell biology.

[149]  M. Grumet.  Nr-CAM: A cell adhesion molecule with ligand and receptor functions , 1997, Cell and Tissue Research.

[150]  A. Planas,et al.  Transforming growth factor-α (TGF-α) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain , 1996, Progress in Neurobiology.

[151]  G. Edelman,et al.  Structure of a new nervous system glycoprotein, Nr-CAM, and its relationship to subgroups of neural cell adhesion molecules , 1991, The Journal of cell biology.

[152]  R. Derynck,et al.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.

[153]  Michael P. Sheetz,et al.  Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility , 1985, Cell.

[154]  Yindi Sun,et al.  circRNA circRIMS Downregulates miR-505 through Methylation to Suppress Cell Proliferation in Endometrial Cancer. , 2022, Critical reviews in eukaryotic gene expression.

[155]  Hong Wang,et al.  MiR-505-5p inhibits proliferation and promotes apoptosis of osteosarcoma cells via regulating RASSF8 expression. , 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[156]  Z. Cai,et al.  WWC3 Inhibits Glioma Cell Proliferation Through Suppressing the Wnt/β-Catenin Signaling Pathway. , 2018, DNA and cell biology.

[157]  Z. Quan,et al.  Knockdown of HMGB1 inhibits cell proliferation and induces apoptosis in hemangioma via downregulation of AKT pathway. , 2017, Journal of biological regulators and homeostatic agents.

[158]  C. Xiaoli,et al.  Lipopolysaccharides‐stimulated macrophage products enhance Withaferin A‐induced apoptosis via activation of caspases and inhibition of NF‐&kgr;B pathway in human cancer cells , 2017, Molecular immunology.

[159]  K. Luo,et al.  Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways. , 2017, Cold Spring Harbor perspectives in biology.

[160]  Liang Chen,et al.  PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells. , 2016, American journal of translational research.

[161]  P. Cheng,et al.  Mucin O-glycan branching enzymes: structure, function, and gene regulation. , 2011, Advances in experimental medicine and biology.

[162]  Herbert J Zeh,et al.  High-mobility group box 1 and cancer. , 2010, Biochimica et biophysica acta.

[163]  M. Štros.  HMGB proteins: interactions with DNA and chromatin. , 2010, Biochimica et biophysica acta.

[164]  Samuel H. Wilson,et al.  HMGB1: roles in base excision repair and related function. , 2010, Biochimica et biophysica acta.